Molecules and mechanisms to overcome oxidative stress inducing cardiovascular disease in cancer patients

F Sabbatino, V Conti, L Liguori, G Polcaro, G Corbi… - Life, 2021 - mdpi.com
Reactive oxygen species (ROS) are molecules involved in signal transduction pathways
with both beneficial and detrimental effects on human cells. ROS are generated by many …

Myocardial protection and current cancer therapy: two opposite targets with inevitable cost

P Efentakis, I Andreadou, KE Iliodromitis… - International Journal of …, 2022 - mdpi.com
Myocardial protection against ischemia/reperfusion injury (IRI) is mediated by various
ligands, activating different cellular signaling cascades. These include classical cytosolic …

3-Methyl-6-nitroindazole in some aqueous co-solvent mixtures: Solubility determination, preferential solvation and solvent effect analysis

W Li, A Farajtabar, R Xing, Y Zhu, H Zhao… - The Journal of Chemical …, 2020 - Elsevier
The equilibrium solubility of 3-methyl-6-nitroindazole in co-solvent mixtures of acetonitrile
(1)+ water (2), ethanol (1)+ water (2) and n-propanol (1)+ water (2) is reported. Experiments …

Yes-associated protein and transcriptional coactivator with PDZ-binding motif as new targets in cardiovascular diseases

Y Yu, X Su, Q Qin, Y Hou, X Zhang, H Zhang… - Pharmacological …, 2020 - Elsevier
As transcriptional co-activators, Yes-associated protein (YAP) and transcriptional coactivator
with PDZ-binding motif (TAZ) can regulate cell proliferation, migration, differentiation, and …

Management of acute coronary syndrome in cancer patients: it's high time we dealt with it

F Luca, I Parrini, MG Abrignani, CM Rao… - Journal of Clinical …, 2022 - mdpi.com
Cancer patients have an increased risk of cardiovascular disease and, notably, a significant
prevalence of acute coronary syndrome (ACS). It has been shown that an elevated presence …

Cancer Treatment-Related Cardiovascular Toxicity in Gynecologic Malignancies: JACC: CardioOncology State-of-the-Art Review

S Parashar, N Akhter, E Paplomata, IY Elgendy… - Cardio Oncology, 2023 - jacc.org
Improvements in early detection and treatment of gynecologic malignancies have led to an
increasing number of survivors who are at risk of long-term cardiac complications from …

Arterial thrombosis in cancer: spotlight on the neglected vessels

ML Canale, I Bisceglia, C Lestuzzi, I Parrini - Anticancer …, 2019 - ar.iiarjournals.org
Cancer patients are at risk for both venous and arterial thrombotic events. Accumulating
evidence suggests a link between cancer and arterial thrombosis events. The …

Cardiovascular toxicity induced by anti-VEGF/VEGFR agents: a special focus on definitions, diagnoses, mechanisms and management

L Jiang, L Ping, H Yan, X Yang, Q He… - Expert Opinion on Drug …, 2020 - Taylor & Francis
Introduction Vascular endothelial growth factor (VEGF) is a key target in cancer therapy.
However, cardiovascular safety has been one of the most challenging aspects of anti …

Cardiovascular toxicities following the use of tyrosine kinase inhibitors in Hepatocellular Cancer Patients: A Retrospective, Pharmacovigilance Study

X Lai, Q Wan, S Jiao, X Sun, J Hu… - Expert Opinion on Drug …, 2024 - Taylor & Francis
ABSTRACT Background Cardiac adverse events (AEs) are common in tyrosine kinase
inhibitors (TKIs). This study explored the cardiac AEs of TKIs through the Food and Drug …

Relation between plasma trough concentration of pazopanib and progression-free survival in metastatic soft tissue sarcoma patients

MS Minot-This, P Boudou-Rouquette, A Jouinot… - Pharmaceutics, 2022 - mdpi.com
Background: Pazopanib (PAZ) is an oral angiogenesis inhibitor approved to treat soft tissue
sarcoma (STS) but associated with a large interpatient pharmacokinetic (PK) variability and …